SHL Medical announces the groundbreaking ceremony for its new site in Taiwan.
Menu
SHL Medical will be in Basel for the Drug-Device Combination Products for Parenteral Use workshop.
Aptar Digital Health, a global leader in digital health solutions connected devices and disease management, and SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems, today announced their strategic partnership.
SHL Medical, a world-leading provider of drug delivery devices, and AARDEX Group, the global leader in medication adherence solutions, today announced their strategic partnership aimed at delivering an end-to-end solution for pharma customers seeking to demonstrate patient adherence within clinical trials.
In the May issue of ONdrug Delivery magazine, SHL Medical explains how we support the advancement of metabolic care with innovative autoinjector technologies.
SHL Medical is pleased to announce our presence at the 29th Congress of the European Society of Biomechanics (ESBiomech) at Edinburgh, Scotland, between June 30-July 3. Following this year’s theme, “Biomechanics from research to practice”, we are excited to share our knowledge on the “Development of silicone-based test model for autoinjector functional performance analysis” by…
SHL Medical, in collaboration with Tech Cluster Zug and esteemed partners, on May 23, 2024, proudly marked a significant milestone with the cornerstone ceremony for its forthcoming flagship headquarters, the “SHL-Südtor” project.
SHL Medical will participate in the PDA Medical Devices and Connected Health Conference, June 4-5, 2024 in Antwerp, Belgium.
SHL Medical furthers its expansion strategy by acquiring SMC Mould Innovation, a Swiss manufacturer specializing in high-performance injection molding tools
